A summary of the iodine supplementation study protocol (I2S2): a UK multicentre randomised controlled trial in

Fiona Williams1, Robert Hume, Simon Ogston

  • 1Population Health Sciences, Medical Research Institute, University of Dundee, Dundee, UK.

Neonatology
|March 1, 2014
PubMed

Insights

This study investigated if iodine supplementation improves neurodevelopment in preterm infants. Researchers aimed to determine if addressing iodine deficiency in parenteral nutrition benefits infant brain development.

Area of Science:

  • Neonatal Medicine
  • Nutritional Science
  • Developmental Neuroscience

Background:

  • Iodine is crucial for thyroxine synthesis, essential for fetal and early childhood brain development.
  • Preterm infants often receive prolonged parenteral nutrition, increasing risk of iodine deficiency.
  • Standard parenteral nutrition solutions may not provide adequate iodine, leading to potential insufficiency.

Purpose of the Study:

  • To outline the protocol for a randomized controlled trial (I2S2 Trial) on iodine supplementation in preterm infants.
  • To assess the impact of iodine supplementation on neurodevelopmental outcomes in this vulnerable population.

Main Methods:

  • A randomized controlled trial (I2S2 Trial) protocol is summarized.
  • The study focuses on preterm infants receiving parenteral nutrition.

Main Results:

  • This section details the study protocol, not yet the results.
  • The trial is designed to collect data on neurodevelopmental benefits.

Conclusions:

  • The I2S2 Trial aims to provide evidence on the necessity of iodine supplementation for preterm infants.
  • Understanding iodine's role in neurodevelopment is critical for optimizing infant nutrition.

Related Concept Videos

Redox Titration: Iodimetry and Iodometry01:23

Redox Titration: Iodimetry and Iodometry

Iodometry and iodimetry are analytical methods used to determine the concentration of oxidizing or reducing agents using iodine. In iodometric titrations, the oxidizing analyte solution is usually acidified and treated with an excess of iodide ions, which generates an equivalent amount of iodine in equilibrium with triiodide. The released iodine is subsequently titrated directly against a standardized reducing agent. As the dilute iodine color becomes pale yellow, a few drops of freshly...
7.0K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K